OUR 9TH YEAR OF PROVIDING PROPRIETARY CAPITAL MARKETS INTELLIGENCE ON THE CANNABIS / HEMP / PSYCHEDELIC SECTORS
M&A Transactions
M&A Transaction Chart
Viridian publishes weekly data on M&A transactions in the Cannabis/CBD/Psychedelic industries. This data includes information about the buyer and seller (public/private, state/country location), deal size, deal structure (cash, stock, earn-out), pricing, share information, and deal implied valuation.
Week ended 05/05/2023
Week ended 05/05/2023
This Section is Only Available to Higher Tier Memberships
Please Purchase a Premium or Enterprise membership to see more.
M&A Transactions Commentary
Week ended 05/05/2023
The Most Interesting Closed M&A Deal of the Week:
- On May 1, 2023, InterCure Ltd (INCR: Nasdaq), a company engaged in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally, closed on the purchase of a 51% stake in Omni Pharmacy Ltd (Private), a Tel Aviv, based company.
- Terms of the transaction were not disclosed.
- InterCure is developing (through a partnership with Kibbutz Nir-Oz) a 1.7 million square foot greenhouse facility in Southern Israel. Approximately 300,000 sq ft of the site is operational and capable of producing up to 7 tons of pharmaceutical-grade cannabis annually.
Week ended 05/05/2023
This is the MA basic
Additional content is available to Premium and Enterprise users. Please purchase a higher tier membership to see more.
Viridian publishes weekly insights on the M&A landscape in the Cannabis/CBD/Psychedelic industries. These insights typically highlight the most interesting/meaningful M&A transactions for that week, and commentary on market conditions, M&A deal structures, target regions for acquirers, and industry sectors ripe for consolidation.